Gateway Advisory’s Amgen AMGN Stock Holding History

Gateway Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$278K	Sell	864 -7	-0.8%	-$2.29K	0.04%	122
2024 Q2	$272K	Hold	871	–	–	0.05%	128
2024 Q1	$248K	Buy	871 +87	+11%	+$25.5K	0.04%	128
2023 Q4	$226K	Buy	+784	New	+$214K	0.04%	120

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gateway Advisory's AMGN Position: Q3 2024 in Review

Gateway Advisory reduced its Amgen (AMGN) stake by 0.8% in Q3 2024, selling an estimated $2.29K and leaving 864 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #122.

Gateway Advisory first reported a position in AMGN in Q4 2023 and has held it in 4 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

Gateway Advisory held 864 shares of Amgen worth $278K as of Q3 2024.
Gateway Advisory sold 7 Amgen shares in Q3 2024, an estimated $2.29K.
Amgen made up 0.04% of Gateway Advisory's portfolio in Q3 2024, its #122 holding.
Gateway Advisory first reported a position in Amgen in Q4 2023 and has held it in 4 quarters since.
2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Gateway Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.